Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF-mobilized PBMCs in Critical Limb Ischemia
NCT01833585Phase 3Completed
- Sponsor
- Mahidol University
- Start
- Apr 2013
- Primary completion
- Dec 2017
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous G-CSF mobilized peripheral blood mononuclear cells in critical limb ischemia (CLI), sponsored by Mahidol University. Started Apr 2013; status: completed.
02
Drugs
autologous G-CSF mobilized peripheral blood mononuclear cells
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT01833585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01833585.